Leap-Bio

Leap-Bio

IP Licensing intermediary services for EArly stage assets in Pharma & BIOtech

Structure

DURATION

18 MONTHS

BUDGET

€ 400.000    

FUNDING

€ 199.000

Project mission

The main goal of the project is to leverage the extensive expertise and networks of the consortium to develop an early-stage focused IP licensing intermediary service for biopharma SMEs and startup companies in the target regions - mainly Portugal, France, and Italy but also Spain and the Wallonian region in Belgium. LEAP-BIO aims at bridging the gap between southern and central and northern European regions in licensing and partnering associated with early-stage assets, driving the growth of the small and medium biopharma companies in such regions and contributing to a more competitive European biopharma industry at a global level.

Project Partners

Eurasanté
ITALBIOTEC Srl
MM Lisboa
Address

Registered office
Piazza della Trivulziana, 4/A
20126 Milan (IT)
Headquarters
Piazza della Trivulziana, 4/A
20126 Milan (IT)